Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 445, pseudogene (RN7SL445P) is a pseudogene, which is a nonfunctional segment of DNA that resembles the sequence of a functional gene, in this case the 7SL RNA gene, a component of the signal recognition particle (SRP)[1][6][7]. Pseudogenes like RN7SL445P are typically generated by reverse transcription of RNA into DNA and integration into the genome; they do not produce functional transcripts or proteins[6][8][9]. RN7SL445P is one of many such 7SL-like pseudogenes dispersed throughout the human genome. These pseudogenes are generally regarded as genomic fossils with no physiological role[8][9]. There are rare cases where certain pseudogenes can regulate gene expression through sequence similarity with their parent gene or by acting as miRNA sponges (ceRNAs)[2], but no evidence indicates any such function for RN7SL445P specifically[1]. This pseudogene is **not an enzyme, receptor, transporter, or other therapeutic target**, nor is it associated with any disease or targeted by any drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 445, pseudogene (RN7SL445P).